None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Healthy males and females. 2)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1) Subjects who take continuous medical treatment. 2) The person who cannot come to the hospital in a designated institution on a designation day. 3) Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 4) Subjects who have contracted or are contracting heart disease, liver disease, kidney disease and digestive disease. 5) diabetic patients. 6) Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift 7) Subjects who have allergic reaction to drug medicine and food. 8) Subjects who donated 200 mL of blood and/or blood components within the last one month prior to the current study. 9) Male subjects who donated 400 mL of blood within the last three months prior to the current study. 10) Female subjects who donated 400 mL of blood within the last four months prior to the current study. 11) Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 12) Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 13) Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks, or who are planning to participate in other clinical study. 14) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy : Accentuation of the grip due to the edible plant oils at 12-week consumption. Safety : Quality of the side effect | — |
Countries
Japan
Contacts
Suntory Global Innovation Center Ltd. Innovation Development Department